치주질환 치료 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2022-2031년)

The report provides revenue of the global periodontal treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global periodontal treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the periodontal treatment market.

The report delves into the competitive landscape of the global periodontal treatment market. Key players operating in the global periodontal treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global periodontal treatment market profiled in this report.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Periodontal Treatment Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Periodontal Treatment Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Disease Prevalence & Incidence Rate globally with key countries
• 5.2. Key Industry Events (mergers & acquisitions, product launches, partnerships, etc.)
• 5.3. Overview on types and causes of Periodontal Disease
• 5.4. Outlook of Major Products used in Surgical and Non-surgical Treatment
• 5.5. Covid-19 Pandemic Impact on the Industry

6. Global Periodontal Treatment Market Analysis and Forecast, by Treatment Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Treatment Type, 2017-2031
  • 6.3.1. Non-surgical Treatment
    • 6.3.1.1. Scaling & Root Planning
    • 6.3.1.2. Antibiotics
      • 6.3.1.2.1. Systemic Antibiotics
      • 6.3.1.2.2. Local Antibiotics
  • 6.3.2. Surgical Treatment
    • 6.3.2.1. Pocket Reduction Surgery
    • 6.3.2.2. Soft Tissue Grafts
    • 6.3.2.3. Bone Grafts
    • 6.3.2.4. Others
• 6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Periodontal Treatment Market Analysis and Forecast, by End-user

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by End-user, 2017-2031
  • 7.3.1. Hospitals
  • 7.3.2. Dental Clinics
  • 7.3.3. Others
• 7.4. Market Attractiveness Analysis, by End-user

8. Global Periodontal Treatment Market Analysis and Forecast, by Region

• 8.1. Key Findings
• 8.2. Market Value Forecast, by Region
  • 8.2.1. North America
  • 8.2.2. Europe
  • 8.2.3. Asia Pacific
  • 8.2.4. Latin America
  • 8.2.5. Middle East & Africa
• 8.3. Market Attractiveness Analysis, by Region

9. North America Periodontal Treatment Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Key Findings
• 9.2. Market Value Forecast, by Treatment Type, 2017-2031
  • 9.2.1. Non-surgical Treatment
    • 9.2.1.1. Scaling & Root Planning
    • 9.2.1.2. Antibiotics
      • 9.2.1.2.1. Systemic Antibiotics
      • 9.2.1.2.2. Local Antibiotics
  • 9.2.2. Surgical Treatment
    • 9.2.2.1. Pocket Reduction Surgery
    • 9.2.2.2. Soft Tissue Grafts
    • 9.2.2.3. Bone Grafts
    • 9.2.2.4. Others
• 9.3. Market Value Forecast, by End-user, 2017-2031
  • 9.3.1. Hospitals
  • 9.3.2. Dental Clinics
  • 9.3.3. Others
• 9.4. Market Value Forecast, by Country, 2017-2031
  • 9.4.1. U.S.
  • 9.4.2. Canada
• 9.5. Market Attractiveness Analysis
  • 9.5.1. By Treatment Type
  • 9.5.2. By End-user
  • 9.5.3. By Country

10. Europe Periodontal Treatment Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Treatment Type, 2017-2031
  • 10.2.1. Non-surgical Treatment
    • 10.2.1.1. Scaling & Root Planning
    • 10.2.1.2. Antibiotics
      • 10.2.1.2.1. Systemic Antibiotics
      • 10.2.1.2.2. Local Antibiotics
  • 10.2.2. Surgical Treatment
    • 10.2.2.1. Pocket Reduction Surgery
    • 10.2.2.2. Soft Tissue Grafts
    • 10.2.2.3. Bone Grafts
    • 10.2.2.4. Others
• 10.3. Market Value Forecast, by End-user, 2017-2031
  • 10.3.1. Hospitals
  • 10.3.2. Dental Clinics
  • 10.3.3. Others
• 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 10.4.1. Germany
  • 10.4.2. U.K.
  • 10.4.3. France
  • 10.4.4. Spain
  • 10.4.5. Italy
  • 10.4.6. Rest of Europe
• 10.5. Market Attractiveness Analysis
  • 10.5.1. By Treatment Type
  • 10.5.2. By End-user
  • 10.5.3. By Country/Sub-region

11. Asia Pacific Periodontal Treatment Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Treatment Type, 2017-2031
  • 11.2.1. Non-surgical Treatment
    • 11.2.1.1. Scaling & Root Planning
    • 11.2.1.2. Antibiotics
      • 11.2.1.2.1. Systemic Antibiotics
      • 11.2.1.2.2. Local Antibiotics
  • 11.2.2. Surgical Treatment
    • 11.2.2.1. Pocket Reduction Surgery
    • 11.2.2.2. Soft Tissue Grafts
    • 11.2.2.3. Bone Grafts
    • 11.2.2.4. Others
• 11.3. Market Value Forecast, by End-user, 2017-2031
  • 11.3.1. Hospitals
  • 11.3.2. Dental Clinics
  • 11.3.3. Others
• 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.4.1. China
  • 11.4.2. Japan
  • 11.4.3. India
  • 11.4.4. Australia & New Zealand
  • 11.4.5. Rest of Asia Pacific
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Treatment Type
  • 11.5.2. By End-user
  • 11.5.3. By Country/Sub-region

12. Latin America Periodontal Treatment Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Treatment Type, 2017-2031
  • 12.2.1. Non-surgical Treatment
    • 12.2.1.1. Scaling & Root Planning
    • 12.2.1.2. Antibiotics
      • 12.2.1.2.1. Systemic Antibiotics
      • 12.2.1.2.2. Local Antibiotics
  • 12.2.2. Surgical Treatment
    • 12.2.2.1. Pocket Reduction Surgery
    • 12.2.2.2. Soft Tissue Grafts
    • 12.2.2.3. Bone Grafts
    • 12.2.2.4. Others
• 12.3. Market Value Forecast, by End-user, 2017-2031
  • 12.3.1. Hospitals
  • 12.3.2. Dental Clinics
  • 12.3.3. Others
• 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.4.1. Brazil
  • 12.4.2. Mexico
  • 12.4.3. Rest of Latin America
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Treatment Type
  • 12.5.2. By End-user
  • 12.5.3. By Country/Sub-region

13. Middle East & Africa Periodontal Treatment Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Treatment Type, 2017-2031
  • 13.2.1. Non-surgical Treatment
    • 13.2.1.1. Scaling & Root Planning
    • 13.2.1.2. Antibiotics
      • 13.2.1.2.1. Systemic Antibiotics
      • 13.2.1.2.2. Local Antibiotics
  • 13.2.2. Surgical Treatment
    • 13.2.2.1. Pocket Reduction Surgery
    • 13.2.2.2. Soft Tissue Grafts
    • 13.2.2.3. Bone Grafts
    • 13.2.2.4. Others
• 13.3. Market Value Forecast, by End-user, 2017-2031
  • 13.3.1. Hospitals
  • 13.3.2. Dental Clinics
  • 13.3.3. Others
• 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.4.1. GCC Countries
  • 13.4.2. South Africa
  • 13.4.3. Rest of Middle East & Africa
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Treatment Type
  • 13.5.2. By End-user
  • 13.5.3. By Country/Sub-region

14. Competition Landscape

• 14.1. Market Player - Competition Matrix (by tier and size of companies)
• 14.2. Market Share/Ranking Analysis, by Company, (2021)
• 14.3. Company Profiles
  • 14.3.1. 3M
    • 14.3.1.1. Company Overview
    • 14.3.1.2. Product Portfolio
    • 14.3.1.3. SWOT Analysis
    • 14.3.1.4. Strategic Overview
  • 14.3.2. AMD Lasers, Inc.
    • 14.3.2.1. Company Overview
    • 14.3.2.2. Product Portfolio
    • 14.3.2.3. SWOT Analysis
    • 14.3.2.4. Strategic Overview
  • 14.3.3. ASA Dental S.p.A.
    • 14.3.3.1. Company Overview
    • 14.3.3.2. Product Portfolio
    • 14.3.3.3. SWOT Analysis
    • 14.3.3.4. Strategic Overview
  • 14.3.4. Biolase, Inc.
    • 14.3.4.1. Company Overview
    • 14.3.4.2. Product Portfolio
    • 14.3.4.3. SWOT Analysis
    • 14.3.4.4. Strategic Overview
  • 14.3.5. Carl Martin GmbH
    • 14.3.5.1. Company Overview
    • 14.3.5.2. Product Portfolio
    • 14.3.5.3. SWOT Analysis
    • 14.3.5.4. Strategic Overview
  • 14.3.6. Danaher
    • 14.3.6.1. Company Overview
    • 14.3.6.2. Product Portfolio
    • 14.3.6.3. SWOT Analysis
    • 14.3.6.4. Strategic Overview
  • 14.3.7. Dentsply Sirona
    • 14.3.7.1. Company Overview
    • 14.3.7.2. Product Portfolio
    • 14.3.7.3. SWOT Analysis
    • 14.3.7.4. Strategic Overview
  • 14.3.8. Deppeler SA
    • 14.3.8.1. Company Overview
    • 14.3.8.2. Product Portfolio
    • 14.3.8.3. SWOT Analysis
    • 14.3.8.4. Strategic Overview
  • 14.3.9. Karl Schumacher
    • 14.3.9.1. Company Overview
    • 14.3.9.2. Product Portfolio
    • 14.3.9.3. SWOT Analysis
    • 14.3.9.4. Strategic Overview
  • 14.3.10. Medtronic
    • 14.3.10.1. Company Overview
    • 14.3.10.2. Product Portfolio
    • 14.3.10.3. SWOT Analysis
    • 14.3.10.4. Strategic Overview
  • 14.3.11. Novartis AG
    • 14.3.11.1. Company Overview
    • 14.3.11.2. Product Portfolio
    • 14.3.11.3. SWOT Analysis
    • 14.3.11.4. Strategic Overview
  • 14.3.12. Pfizer, Inc.
    • 14.3.12.1. Company Overview
    • 14.3.12.2. Product Portfolio
    • 14.3.12.3. SWOT Analysis
    • 14.3.12.4. Strategic Overview
  • 14.3.13. Planmeca Oy
    • 14.3.13.1. Company Overview
    • 14.3.13.2. Product Portfolio
    • 14.3.13.3. SWOT Analysis
    • 14.3.13.4. Strategic Overview
  • 14.3.14. Steris-Hu-Friedy
    • 14.3.14.1. Company Overview
    • 14.3.14.2. Product Portfolio
    • 14.3.14.3. SWOT Analysis
    • 14.3.14.4. Strategic Overview
  • 14.3.15. Straumann AG
    • 14.3.15.1. Company Overview
    • 14.3.15.2. Product Portfolio
    • 14.3.15.3. SWOT Analysis
    • 14.3.15.4. Strategic Overview